Gastroretentive Drug Delivery Systems Market
Global Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (High-Density Systems, Expandable Drug Delivery Systems, Bioadhesive Drug Delivery Systems, Floating Drug Delivery Systems and Others) By Dosage Forms (Tablets, Liquid, Microspheres, Capsule, and Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Forecast, 2021-2027 Update Available - Forecast 2024-2030
The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period (2021-2027). The gastroretentive drug delivery systems are gaining popularity in the oral drug delivery systems. These systems are used for the retention of drug dosage in the stomach for an extended period of time and release the drug slowly. These devices facilitate overcoming the challenges associated with conventional oral delivery, including poor bioavailability. Therefore, many pharmaceutical companies are now focusing on developing gastroretentive drug delivery systems (DDSs) by investing a high amount this is the major factor driving the growth of the market. Other than that, the rising prevalence of functional gastrointestinal disorders (FGIDs), gastric disorders such as helicobacter pylori infection, and ulcers, and small intestine-related disorders are anticipated to foster the demand for such DDS systems due to their proven efficacy in the treatment of these disorders. For instance, according to the global survey of FGIDs conducted by the World Gastroenterology Organisation on 73,000 people in 33 countries. Around 49% of the women and 37% of the men met the diagnostic criteria for at least one FGID. According to the same, for every 10 adults in the world, 4 suffer from FGID. Whereas the rising prevalence of Helicobacter pylori infection, which is the major cause of gastroduodenal ulcer disease, is higher in developing countries globally, that further anticipated to drive their adoption during the forecast period.
Moreover, the increasing number of hospitals and retail pharmacies globally, high investment by major players on R&D activities for the product quality, and rising partnership collaborations among players for the expansion of their business is further projected to augment the growth of the market during the forecast period.
Impact of COVID-19 on Global Gastroretentive Drug Delivery Systems Market
The global gastroretentive DDS system market is lightly impacted by the COVID-19 pandemic. The global pandemic has catalyzed the demand for effective drugs. Due to increased demand for drugs related to gastric disorder a significant increase in the demand for gastroretentive DDS systems has been witnessed. However, due to a halt in production units owing to the poor raw material supply, the market has experienced a mild impact. On the other hand, increasing demand and online prescriptions, during the lockdown resulted in now major changes in market growth.
Segmental Outlook
The global Gastroretentive Drug Delivery Systems market is segmented based on type, dosage form, and distribution channel. Based on type, the market is segregated into high-density systems, expandable drug delivery systems, bioadhesive drug delivery systems, floating drug delivery systems, and others. Among these, the floating drug delivery system dominated the market in 2020, and it is further anticipated to maintain its dominant position during the forecast period. These drugs delivery systems help to increase the gastric retention time along with improved control over fluctuation in plasma drug concentration. Hence accelerating the segment growth. Based on dosage form, the market is categorized into capsule, microspheres, tablets, liquid, and others. The tablet segment is expected to account for the largest share in the market due to the increasing manufacturing of gastroretentive tablets by manufacturers in the market. The capsule segment is projected to witness healthy growth during the forecast period. Likewise, based on distribution channels, the market is categorized into retail pharmacies, online pharmacies, and hospital pharmacies.
Global Gastroretentive Drug Delivery Systems Market Share by Distribution Channel, 2020 (%)
The Hospital Segment is Projected to Hold the Significant Share in the Global Gastroretentive DDS Market
Among distribution channels, the hospital segment is anticipated to grow at significant CAGR during the forecast period. The increasing investment in the development of healthcare infrastructure is the major factor due to which the number of hospitals is now increasing across the globe. Various economies around the world are now investing a high share of their GDP in the development of hospitals and pharmacies so that the delivery of essential drugs and other medical devices can be done inefficient way. The hospital provides the necessary services for acute and complex conditions coupled with advanced medical devices and equipment. The increasing number of hospitals in developing countries owing to the rising gastric disorders globally will accelerate the need for effective gastroretentive DDS systems, which in turn, further support the growth of the market during the forecast period.
Regional Outlook
Geographically, the global Gastroretentive Drug Delivery Systems market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, Asia-Pacific is expected to show a lucrative growth rate during the forecast period. The presence of a large patient pool affected with gastroretentive disorders is the major factor increasing the adoption of gastroretentive DDS systems. Whereas the increasing R&D spending in emerging economies such as China, Japan, India, and Singapore, and new launches by major players will also support the market to grow in the region during the forecast period. Europe is likely to hold a considerable share in the market. The well-established healthcare infrastructure and improved services are expected to contribute to the market growth.
Global Gastroretentive Drug Delivery Systems Market Growth, By Region 2021-2027
North America Holds the Dominant Position in Global Gastroretentive Drug Delivery Systems Market
Geographically, North America has dominated the market in 2020, and it will again be projected to dominate the market by accounting largest market share during the forecast period. The rising prevalence of gastric cancer among the elderly population in the region is due to which the adoption of gastroretentive DDS systems is increasing in the healthcare sector. Apart from these, the growing healthcare infrastructure and high investment by major players for the further R&D of drugs delivery systems is also fueling the market growth. In North America, the US accounts for the major share owing to the presence of major players and strategies adopted by them to expand their business for increasing the availability of drugs and devices across the region. In addition, the prevalence of diseases is also high in the US, which leads to the adoption of advanced treatment methodologies in the medical sector.
Market Players Outlook
The key players in the gastroretentive drug delivery systems market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include F. Hoffmann-La Roche AG, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Assertio Holdings, Inc., Alcon Vision LLC, Lupin, Pfizer Inc., and others.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Gastroretentive Drug Delivery Systems market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Gastroretentive Drug Delivery Systems Industry
• Recovery Scenario of Global Gastroretentive Drug Delivery Systems Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Gastroretentive Drug Delivery Systems Market by Type
5.1.1. High Density Systems
5.1.2. Expandable Drug Delivery Systems
5.1.3. Bioadhesive Drug Delivery Systems
5.1.4. Floating Drug Delivery Systems
5.1.5. Others
5.2. Global Gastroretentive Drug Delivery Systems Market by Dosage form
5.2.1. Capsule
5.2.2. Microspheres
5.2.3. Tablets
5.2.4. Liquid
5.2.5. Others
5.3. Global Gastroretentive Drug Delivery Systems Market by Distribution Channel
5.3.1. Retail Pharmacies
5.3.2. Hospital Pharmacies
5.3.3. Online Pharmacies
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. ASEAN
6.3.5. South Korea
6.3.6. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Alcon Vision LLC
7.2. Assertio Holdings, Inc.
7.3. F. Hoffmann La Roche
7.4. GlaxoSmithKline PLC
7.5. Lupin
7.6. Pfizer Inc
7.7. Pharmacia
7.8. Sun Pharmaceutical Industries Ltd
1. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
2. GLOBAL HIGH DENSITY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
3. GLOBAL EXPANDABLE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
4. GLOBAL BIOADHESIVE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
5. GLOBAL FLOATING DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
6. GLOBAL OTHERS GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
7. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
8. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR TABLETS RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR LIQUID RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR MICROSPHERES RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
11. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR CAPSULES RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
12. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR OTHERS DOSAGE FORMS RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
13. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
14. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
15. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
16. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
17. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
18. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
19. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
20. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
21. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
22. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
23. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
24. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
25. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
26. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
27. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
28. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
29. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
30. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
31. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL INDUSTRY, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET, 2020-2027($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2020-2027($ MILLION)
3. RECOVERY OF GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET, 2021-2027(%)
4. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY TYPE, 2020 VS 2027 (%)
5. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY DOSAGE FORM, 2020 VS 2027 (%)
6. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
7. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
8. GLOBAL HIGH DENSITY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL EXPANDABLE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL BIOADHESIVE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
11. GLOBAL FLOATING DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
12. GLOBAL OTHERS GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
13. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR TABLETS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
14. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR LIQUID MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
15. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR MICROSPHERES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
16. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR CAPSULES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
17. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR OTHERS DOSAGE FORMS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
18. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN HOSPITAL PHARMACIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
19. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN RETAIL PHARMACIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
20. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN ONLINE PHARMACIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
21. US GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
22. CANADA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
23. UK GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
24. FRANCE GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
25. GERMANY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
26. ITALY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
27. SPAIN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
28. ROE GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
29. INDIA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
30. CHINA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
31. JAPAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
32. ASEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
33. SOUTH KOREA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
34. REST OF ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
35. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET SIZE, 2020-2027 ($ MILLION)
